Board of Scientific Advisors
Guided by leading physicians, clinical researchers, and biotechnology innovators, Ascenda advances scientific exploration at the intersection of peptide biology, regenerative science, and nanotechnology-driven research systems.
Scientific Leadership & Research Focus
Ascenda Peptides operates at the intersection of peptide biology, regenerative science, microbiome research, and nanotechnology-driven laboratory systems. Guided by the Ascenda Board of Scientific Advisors, the company advances scientific exploration into peptide signaling pathways and next-generation research environments designed to support emerging biological discovery.
The Board brings together physicians, clinical researchers, and biotechnology innovators whose expertise spans regenerative medicine, metabolic science, psychoneuroimmunology, microbiome biology, mitochondrial function, and nanotechnology. Their collective experience provides strategic scientific guidance for Ascenda's research direction and technology development.
Through interdisciplinary collaboration, the board supports Ascenda's commitment to rigorous scientific exploration and the responsible advancement of peptide-based research systems.
Areas of Collective Expertise
Ascenda Board of Scientific Advisors
Dr. Andrew J.M. Willoughby
DMD, LVIF, FAGD, FICCMO, FICOI, FAACFP, MICCMO
Dr. Willoughby is a highly respected Dental Clinician with over 38 years experience. Andrew is an innovator and and Inventor who holds dozens of international Patents in the area of Nanotechnology and Regenerative medicine. Dr. Willoughby’s focus is on establishing and developing novel molecular level interactions b/w advanced biological systems / living tissue and Nanotechnology.
His research into NanoMetallic Silver Oxide technologies provides foundational scientific direction for Ascenda's NanoMatrix™ platform, which explores how nanostructured materials may influence peptide stability, biochemical signaling environments, and molecular interactions within laboratory research systems.
Dr. Manuel Riegner
MD
Dr. Manuel Riegner brings expertise in integrative medicine, metabolic psychiatry, psychoneuroimmunology, and longevity-focused systems biology. His work examines the interconnected relationship between biology, behavior, metabolism, and inflammation, with a strong emphasis on the foundational drivers of human performance and systemic resilience.
Within Ascenda's scientific framework, Dr. Riegner contributes insight into peptide-related research areas involving microbiome balance, mitochondrial biology, neuroimmune signaling, and whole-system metabolic regulation, helping support a broader systems-based understanding of peptide science.
Dr. Paul Sidhu
MD, CCFP
Dr. Sidhu contributes extensive clinical experience in preventive medicine, metabolic health, and systemic biological regulation. His work focuses on understanding the physiological pathways involved in inflammation, cellular repair mechanisms, and metabolic balance.
Within Ascenda's research framework, Dr. Sidhu provides clinical perspective on emerging peptide compounds and their potential roles in biological signaling pathways related to tissue response, metabolic regulation, and cellular resilience.
Dr. Gabriel Alizaidy
MD,MS
Dr. Gabriel Alizaidy specializes in precision medicine and advanced therapeutic research focused on optimizing human physiology through emerging biomedical technologies.
His expertise in peptide signaling systems and translational medicine supports Ascenda's research into peptide compounds involved in metabolic regulation, mitochondrial biology, performance optimization, and cellular regeneration pathways.
Dr. Kendall Skinner
Dr. Kendall Skinner brings nearly 25 years of clinical expertise in comprehensive physiologic based dentistry, specializing in the integration of nanotechnology and advanced therapeutic modalities.
His clinical approach focuses on systemic health and performance through custom mito-epigenetic optimization protocols, bridging molecular science with targeted interventions involving peptides, advanced supplementation, and metabolic regulation.
Dr. Leigh J Mack
MD, PhD(Nano), FAPCR, CPI
Dr Leigh J Mack, MD, PhD (Nano) has over 30 years of expertise as a Physician who specializes in advanced therapeutic research focused on optimizing human physiology with Nanotechnology.
Scientific Areas of Focus
Peptide Signaling Systems
Peptides act as biological messengers that regulate complex physiological processes. Ascenda supports research investigating how peptide sequences influence cellular communication, biochemical signaling, and systemic biological regulation.
Regenerative Biology
Many peptides participate in biological processes associated with cellular repair and tissue signaling. Ascenda explores these pathways to better understand how peptides interact with regenerative biological systems.
Metabolic & Mitochondrial Biology
Research continues to examine the role of peptide signaling in metabolic regulation and mitochondrial function — two critical components of cellular energy, biological adaptation, and physiological resilience.
Microbiome & Systems Biology
Ascenda supports exploration into peptide interactions involving oral and gut microbiome environments, immune signaling, and neuroimmune-metabolic pathways — reinforcing the role of microbial ecosystems in whole-body regulation.
Nanotechnology Integration
Ascenda's NanoMatrix™ platform studies how nanostructured materials may support advanced peptide stability, signaling interactions, and laboratory performance within research environments.
Precision Medicine
Translational research bridging molecular biology and clinical application, supporting the development of next-generation peptide compounds with precision-targeted biological activity.
NanoMatrix™ Technology Platform
A central component of Ascenda's scientific work is the development and investigation of NanoMatrix™ technology — an advanced research platform designed to study how nanostructured materials interact with peptide compounds within laboratory environments.
By studying the relationship between nanostructured materials and peptide compounds, Ascenda seeks to deepen scientific understanding of biological signaling systems, regenerative molecular pathways, and advanced laboratory applications.
- Peptide stability and structural integrity
- Molecular signaling environments
- Microbial and biochemical interactions
- Advanced peptide research systems
- USP-51 validated antimicrobial preservation
NanoMatrix™
Next-generation nano-metallic silver oxide research matrix — engineered at the nanoscale for superior peptide preservation and stability.
Advancing the Future of Peptide Research
Through the combined expertise of the Ascenda Board of Scientific Advisors, Ascenda Peptides continues to pursue interdisciplinary scientific exploration at the intersection of peptide biology, regenerative science, systems medicine, microbiome research, and nanotechnology. Ascenda remains committed to responsible scientific advancement and the continued exploration of peptide-driven innovation.
Connect with Our Scientific TeamResearch Use Disclaimer
All products offered by Ascenda Peptide Labs are intended for laboratory research and educational use only. They are not for human consumption, medical use, diagnosis, treatment, or veterinary application. Products have not been evaluated by Health Canada, the FDA, or any regulatory authority for clinical use. No claims are made regarding safety or efficacy for any purpose beyond research.
Ascenda Peptide Labs does not provide medical advice. By purchasing, the buyer assumes full responsibility for proper handling and use in compliance with all applicable laws and regulations.